Folic acid cuts risk of premature birth

Feb 01, 2008

A U.S study suggests that women who take folic acid supplements before they become pregnant can cut their risk of having a premature baby by half.

The report, presented Thursday at the annual Society for Maternal-Fetal Medicine meeting, said taking folate supplements for at least one year before becoming pregnant reduced premature delivery by 50 percent to 70 percent.

Babies who are born very premature are at the greatest risk of complications such as cerebral palsy, mental retardation, chronic lung disease and blindness.

The findings were based on observational analysis of folate supplementation by 38,033 participants in an earlier trial sponsored by the National Institutes of Health.

"Thanks to the depth and breadth of the NIH study, which included an early pregnancy ultrasound of each participant, we had highly accurate evidence of the gestational ages of the preterm deliveries," Dr. Radek Bukowski of the University of Texas Medical Branch at Galveston said in a release.

Folate supplements were linked to a 70 percent decrease in very early preterm deliveries between 20 to 28 weeks in gestational age, and up to a 50 percent reduction in early preterm deliveries of 28 to 32 weeks.

Copyright 2008 by United Press International

Explore further: Simulation-based training improves endoscopy execution

add to favorites email to friend print save as pdf

Related Stories

Researchers find clues to mystery of preterm delivery

Feb 10, 2011

Researchers at Yale School of Medicine have found that excessive formation of calcium crystal deposits in the amniotic fluid may be a reason why some pregnant women suffer preterm premature rupture of the membranes (PPROM) ...

Recommended for you

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments : 0